IBS Software, a leading SaaS provider, sees growth opportunities in India's airlines and loyalty programs. The company aims ...

However, ondansetron which is available worldwide, seems to be a promising safe alternative for IBS-D patients, but large clinical trials are still needed. Rifaximin, which is a broad-spectrum, ...

"Although we're yet to conclusively pinpoint specific genes and mechanisms, these findings provide novel insights into IBS ...